183 related articles for article (PubMed ID: 37768526)
1. The triglycerides and glucose index is more strongly associated with metabolically healthy obesity phenotype than the lipid and obesity indices.
Weyman-Vela Y; Guerrero-Romero F; Simental-Mendía LE
J Endocrinol Invest; 2024 Apr; 47(4):865-871. PubMed ID: 37768526
[TBL] [Abstract][Full Text] [Related]
2. The Association between Cardio-metabolic and hepatic indices and anthropometric measures with metabolically obesity phenotypes: a cross-sectional study from the Hoveyzeh Cohort Study.
Zakerkish M; Hoseinian A; Alipour M; Payami SP
BMC Endocr Disord; 2023 May; 23(1):122. PubMed ID: 37246210
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Risk Factors Associated With the Metabolically Healthy Obese (MHO) Phenotype Compared to the Metabolically Unhealthy Obese (MUO) Phenotype in Children.
Genovesi S; Antolini L; Orlando A; Gilardini L; Bertoli S; Giussani M; Invitti C; Nava E; Battaglino MG; Leone A; Valsecchi MG; Parati G
Front Endocrinol (Lausanne); 2020; 11():27. PubMed ID: 32117055
[No Abstract] [Full Text] [Related]
4. Association of cumulative excess weight and waist circumference exposure with transition from metabolically healthy obesity to metabolically unhealthy.
Jahromi MK; Ebadinejad A; Barzin M; Mahdavi M; Niroomand M; Khalili D; Valizadeh M; Azizi F; Hosseinpanah F
Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2544-2552. PubMed ID: 36163212
[TBL] [Abstract][Full Text] [Related]
5. Adherence to the Mediterranean diet as a possible additional tool to be used for screening the metabolically unhealthy obesity (MUO) phenotype.
Barrea L; Verde L; Simancas-Racines D; Zambrano AK; Frias-Toral E; Colao A; Savastano S; Muscogiuri G
J Transl Med; 2023 Sep; 21(1):675. PubMed ID: 37770999
[TBL] [Abstract][Full Text] [Related]
6. Association between obese phenotypes and risk of carotid artery plaque among chinese male railway drivers.
Pan J; Wang Z; Dong C; Yang B; Tang L; Jia P; Yang S; Zeng H
BMC Public Health; 2022 Oct; 22(1):1859. PubMed ID: 36199053
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive metabolic profiling of the metabolically healthy obesity phenotype.
Telle-Hansen VH; Christensen JJ; Formo GA; Holven KB; Ulven SM
Lipids Health Dis; 2020 May; 19(1):90. PubMed ID: 32386512
[TBL] [Abstract][Full Text] [Related]
8. Magnesium intake is associated with the metabolically healthy obese phenotype.
Guerrero-Romero F; Morales-Gurrola G; Preza-Rodríguez L; Gómez-Barrientos A; Olivas-Martínez AI; Simental-Mendía LE
J Investig Med; 2022 Mar; 70(3):800-804. PubMed ID: 34725202
[TBL] [Abstract][Full Text] [Related]
9. Metabolically Healthy Obesity (MHO) vs. Metabolically Unhealthy Obesity (MUO) Phenotypes in PCOS: Association with Endocrine-Metabolic Profile, Adherence to the Mediterranean Diet, and Body Composition.
Barrea L; Muscogiuri G; Pugliese G; de Alteriis G; Colao A; Savastano S
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836180
[TBL] [Abstract][Full Text] [Related]
10. Comparison between metabolically healthy obesity and metabolically unhealthy obesity by different definitions among Mexican children.
Evia-Viscarra ML; Guardado-Mendoza R
J Pediatr Endocrinol Metab; 2020 Feb; 33(2):215-222. PubMed ID: 31834862
[TBL] [Abstract][Full Text] [Related]
11. Correlation analysis of obesity phenotypes with leptin and adiponectin.
Aisike G; Kuerbanjiang M; Muheyati D; Zaibibuli K; Lv MX; Han J
Sci Rep; 2023 Oct; 13(1):17718. PubMed ID: 37853077
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical characteristics of metabolically healthy obese versus metabolically unhealthy obese school children.
Wan Mohd Zin RM; Jalaludin MY; Yahya A; Nur Zati Iwani AK; Md Zain F; Hong JYH; Mokhtar AH; Wan Mohamud WN
Front Endocrinol (Lausanne); 2022; 13():971202. PubMed ID: 36072927
[TBL] [Abstract][Full Text] [Related]
13. Body Composition and Cardiorespiratory Fitness Between Metabolically Healthy Versus Metabolically Unhealthy Obese Black and White Adolescents.
Lee S; Arslanian S
J Adolesc Health; 2019 Mar; 64(3):327-332. PubMed ID: 30389203
[TBL] [Abstract][Full Text] [Related]
14. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
Hosseinpanah F; Tasdighi E; Barzin M; Mahdavi M; Ghanbarian A; Valizadeh M; Azizi F
PLoS One; 2020; 15(9):e0239164. PubMed ID: 32947607
[TBL] [Abstract][Full Text] [Related]
15. The effect of metabolic health and obesity phenotypes on risk of hypertension: A nationwide population-based study using 5 representative definitions of metabolic health.
Tian S; Xu Y; Dong H
Medicine (Baltimore); 2018 Sep; 97(38):e12425. PubMed ID: 30235720
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance persists despite a metabolically healthy obesity phenotype.
Hoddy KK; Axelrod CL; Mey JT; Hari A; Beyl RA; Blair JB; Dantas WS; Kirwan JP
Obesity (Silver Spring); 2022 Jan; 30(1):39-44. PubMed ID: 34816598
[TBL] [Abstract][Full Text] [Related]
17. TyG Index Change Is More Determinant for Forecasting Type 2 Diabetes Onset Than Weight Gain.
Navarro-González D; Sánchez-Íñigo L; Fernández-Montero A; Pastrana-Delgado J; Martinez JA
Medicine (Baltimore); 2016 May; 95(19):e3646. PubMed ID: 27175686
[TBL] [Abstract][Full Text] [Related]
18. Metabolically healthy obesity in children enrolled in the CANadian Pediatric Weight management Registry (CANPWR): An exploratory secondary analysis of baseline data.
Damanhoury S; Morrison KM; Mian R; McPhee PG; Kozyrskyj AL; Newton AS; Buchholz A; Chanoine JP; Hamilton J; Ho J; Laberge AM; Legault L; Thabane L; Tremblay MS; Zenlea I; Ball GDC
Clin Obes; 2022 Feb; 12(1):e12490. PubMed ID: 34617401
[TBL] [Abstract][Full Text] [Related]
19. Differences in vitamin D concentration between metabolically healthy and unhealthy obese adults: associations with inflammatory and cardiometabolic markers in 4391 subjects.
Esteghamati A; Aryan Z; Esteghamati A; Nakhjavani M
Diabetes Metab; 2014 Nov; 40(5):347-55. PubMed ID: 24811744
[TBL] [Abstract][Full Text] [Related]
20. Associations of obesity phenotypes with weight change, cardiometabolic benefits, and type 2 diabetes incidence during a lifestyle intervention: results from the PREVIEW study.
Zhu R; Huttunen-Lenz M; Stratton G; Handjieva-Darlenska T; Handjiev S; Sundvall J; Silvestre MP; Jalo E; Pietiläinen KH; Adam TC; Drummen M; Simpson EJ; Taylor MA; Poppitt SD; Navas-Carretero S; Martinez JA; Schlicht W; Fogelholm M; Brand-Miller J; Raben A
Int J Obes (Lond); 2023 Sep; 47(9):833-840. PubMed ID: 37420008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
